Document:

exv4w1

 

Exhibit 4.1

THIS WARRANT AND THE SHARES OF STOCK ISSUABLE UPON EXERCISE HEREOF HAVE NOT BEEN
REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR UNDER THE
SECURITIES LAWS OF CERTAIN STATES. THESE SECURITIES ARE SUBJECT TO RESTRICTIONS ON
TRANSFERABILITY AND RESALE AND MAY NOT BE TRANSFERRED OR RESOLD EXCEPT AS PERMITTED UNDER
THE SECURITIES ACT AND THE APPLICABLE STATE SECURITIES LAWS, PURSUANT TO REGISTRATION OR
EXEMPTION THEREFROM. INVESTORS SHOULD BE AWARE THAT THEY MAY BE REQUIRED TO BEAR THE
FINANCIAL RISKS OF THIS INVESTMENT FOR AN INDEFINITE PERIOD OF TIME. THE ISSUER OF THESE
SECURITIES MAY REQUIRE AN OPINION OF COUNSEL IN FORM AND SUBSTANCE SATISFACTORY TO THE
ISSUER TO THE EFFECT THAT ANY PROPOSED TRANSFER OR RESALE IS IN COMPLIANCE WITH THE
SECURITIES ACT AND ANY APPLICABLE STATE SECURITIES LAWS.

February 24, 2005

WARRANT TO PURCHASE SHARES OF

COMMON STOCK OF

SinoFresh HealthCare, Inc.

     THIS CERTIFIES THAT for value received, AdSouth Partners, Inc., (together with successors and
assigns, the “Holder”), is entitled to subscribe for and purchase One Hundred Thousand (100,000)
shares (the “Shares”) of Common Stock, no par value per share, of SinoFresh Healthcare, Inc., a
Florida corporation (the “Company”), at an exercise price per share of Common Stock equal to One
Dollar ($1.00) (the “Exercise Price”), subject to the provisions and upon the terms and conditions
set forth herein. This Warrant is being issued pursuant to that certain engagement letter with the
Company dated February 12 , 2005 (the “Letter”).

     1. Term. This Warrant is exercisable at any time prior to February 25 , 2010 (the
“Exercise Period”).

     2. Exercise of Warrant. There is no obligation to exercise all or any portion of the
Warrant. The Warrant (or any portion thereof) may be exercised at any time after the date hereof
only by delivery to the Company of:

     (a) Written notice of exercise in form and substance identical to Exhibit A attached
to this Warrant; and

     (b) Payment of the Exercise Price of the Shares being purchased, may be made by (1) cash or by
check, (2) cancellation of indebtedness of the Company to the Holder equal to the Exercise Price,
(3) a cashless exercise procedure pursuant to a formula (“Formula Cashless Exercise”), or (4) any
combination of the foregoing. In the event of a Formula Cashless Exercise, the Holder shall
surrender this Warrant to the Company with a written notice of the Holder’s intention to effect a
cashless exercise, including a calculation of the number of shares of Common Stock to be issued
upon such exercise in
accordance with the terms hereof; and, in lieu of paying the Exercise Price in cash, the
Holder shall surrender this Warrant for that number of shares of Common Stock determined by
multiplying the number of Shares to which it would otherwise be entitled by a fraction, the
numerator of which shall be the difference between (i) the average Market Price per share of the
Common Stock for the five (5) Trading Days immediately prior to the date of delivery of the
cashless exercise notice to the Company

 

 

(the “Cashless Exercise Market Price”) and (ii) the
Exercise Price, and the denominator of which shall be the Cashless Exercise Market Price. As used
herein, “Market Price” means, as of any Trading Day, (i) the closing sale price for the shares of
Common Stock on the NASD OTC Bulletin Board (“OTCBB”) as reported by Bloomberg, or (ii) if the
OTCBB is not the principal trading market for the shares of Common Stock, the closing sale price on
the principal trading market for the Common Stock as reported by Bloomberg, or (iii) if market
value cannot be calculated as of such date on any of the foregoing basis, the Market Price shall be
the fair market value as reasonably determined in good faith by the Company’s Board of Directors.
As used herein, a “Trading Day” shall mean any day on which the Company’s Common Stock is traded
for any period on the OTCBB, or on the principal securities exchange or other securities market on
which the Company’s Common Stock is then being traded

     3. Issuance of Certificates. Upon the exercise of this Warrant, the issuance of
certificates for Shares underlying this Warrant shall be made forthwith, and such certificates
shall be issued (subject to the provisions of Section 4 hereof) in the name of, or in such names as
may be directed by, the Holder hereof; provided, however, that the Company shall not be required to
pay any tax which may be payable in respect of any transfer involved in the issuance and delivery
of any such certificates in a name other than that of the Holder, and the Company shall not be
required to issue or deliver such certificates unless or until the person or persons requesting the
issuance thereof shall have paid to the Company the amount of such tax or shall have established to
the satisfaction of the Company that such tax has been paid. The person or persons in whose
name(s) any certificate(s) representing Shares shall be issued upon exercise hereof shall be deemed
to have become the holder(s) of record of, and shall be treated for all purposes as the record
holder(s) of, the Shares represented thereby, and such Shares shall be deemed to have been issued,
immediately prior to the close of business on the date(s) upon which this Warrant is exercised.

     4. Restrictions on Exercise and Transfer.

          4.1 Exercise. As a condition to the exercise hereof, the Holder shall make any
truthful representation or warranty reasonably required to facilitate the application of any
exemption(s) from federal and state registration requirements in connection therewith.

          4.2 Holder’s Intent. The Holder of this Warrant, by acceptance hereof, represents and
warrants to the Company that such Holder is acquiring this Warrant and the Shares for investment
for the Holder’s own account and not with a view to, or for resale in connection with, any
distribution thereof.

          4.3 Transfer. Neither this Warrant nor the Shares have been registered under the
Securities Act, and none of the foregoing may be sold or transferred in whole or in part unless the
Holder shall have first given notice to the Company describing such sale or transfer and furnished
to the Company an opinion of counsel (which counsel and opinion (in form and substance) shall be
reasonably satisfactory to the
Company) to the effect that the proposed sale or transfer may be made without registration
under the Securities Act.

          4.4 Legends. Each certificate representing Shares purchased hereunder shall bear the
following legends:

2

 

THE SHARES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES
ACT OF 1933, AS AMENDED, AND MAY NOT BE SOLD, TRANSFERRED, ASSIGNED,
PLEDGED, OR HYPOTHECATED UNLESS AND UNTIL REGISTERED UNDER SUCH ACT, OR
UNLESS THE CORPORATION HAS RECEIVED AN OPINION OF COUNSEL OR OTHER EVIDENCE,
SATISFACTORY TO THE COMPANY AND ITS COUNSEL, THAT SUCH REGISTRATION IS NOT
REQUIRED.

THE CORPORATION IS AUTHORIZED TO ISSUE MORE THAN ONE CLASS OF STOCK. THE
CORPORATION WILL FURNISH IN WRITING AND WITHOUT CHARGE TO EACH STOCKHOLDER
WHO SO REQUESTS A STATEMENT OF THE POWERS, DESIGNATIONS, PREFERENCES AND
RELATIVE PARTICIPATION, OPTIONAL OR OTHER SPECIAL RIGHTS OF EACH CLASS OF
STOCK AND THE QUALIFICATIONS, LIMITATIONS OR RESTRICTION OF SUCH PREFERENCES
AND/OR RIGHTS.

     5. Adjustment of Exercise Price and Number of Shares for Subdivision or Combination of
Common Stock.

          5.1 Adjustments.

               (1) Subdivision. In the event that the Company at any time or from time to time after
the date of this Warrant shall declare or pay any dividend on the shares of Common Stock payable in
shares of Common Stock or in any right to acquire shares of Common Stock, or shall effect a
subdivision of the outstanding shares of Common Stock into a greater number of shares of Common
Stock (by stock split, reclassification or otherwise), then the Exercise Price in effect
immediately prior to such event shall, concurrently with the effectiveness of such event, be
decreased proportionately.

               (2) Combination. In the event that at any time or from time to time after the date of
this Warrant the outstanding shares of Common Stock shall be combined or consolidated into a lesser
number of shares of Common Stock (by reclassification or otherwise), then the Exercise Price in
effect immediately prior to such event shall, concurrently with the effectiveness of such event, be
increased proportionately.

          5.2 Adjustment for Reclassification, Exchange, or Substitution. In the event of any
reorganization or any reclassification of the capital stock of the Company, any consolidation or
merger of the Company with or into another corporation or corporations or the conveyance of all or
substantially all of the Company’s assets to another corporation (except for any such transaction
which is treated as a liquidation, dissolution or winding up of the Company), this Warrant shall
thereafter be exercisable for the number of shares of stock or other securities or property
(including cash) to which a holder of the number of remaining Shares purchasable hereunder would
have been entitled upon the record date of (or date of, if no record date is fixed) such
reorganization,
reclassification, consolidation, merger or conveyance; and, in any case, appropriate
adjustment (as determined by the Board of Directors) shall be made in the application of the
provisions herein set forth with respect to the rights and interests thereafter of the Holder of
this Warrant to the end that the provisions set forth herein shall thereafter be applicable, as
nearly as equivalent as is practicable, in relation to any shares of stock or the securities or
property (including cash) thereafter deliverable upon the exercise of this Warrant.

          5.3 Adjustment to Number of Shares Purchasable Hereunder. Upon each adjustment of the
Exercise Price pursuant to the provisions of this Section 5, the number of Shares purchasable upon

3

 

the exercise hereof shall be adjusted to the nearest whole number of Shares calculated by
multiplying the Exercise Price in effect immediately prior to such adjustment by the number of
Shares purchasable upon the exercise hereof immediately prior to such adjustment and dividing the
product so obtained by the Exercise Price in effect immediately after such adjustment.

     6. Exchange and Replacement of Certificate.

          6.1 This Warrant is exchangeable without expense, upon the surrender hereof by the
registered Holder at the principal office of the Company, for a new Warrant of like tenor and date
representing in the aggregate the right to purchase the same number of Shares as are purchasable
hereunder in such denominations as shall be designated by the Holder hereof at the time of such
surrender.

          6.2 Upon receipt by the Company of evidence reasonably satisfactory to the Company
of the loss, theft, destruction or mutilation of this Warrant, and, in case of loss, theft or
destruction, of indemnity or security reasonably satisfactory to the Company, and return and
cancellation of this Warrant, if mutilated, the Company will make and deliver a new Warrant of like
tenor, in lieu of this Warrant.

     7. Elimination of Fractional Interests. The Company shall not be required to issue
certificates representing fractions of Shares on the exercise of this Warrant, nor shall it be
required to issue scrip or pay cash in lieu of fractional interests, it being the intent of the
parties that all fractional interests shall be eliminated.

     8. Withholding Taxes.

          8.1 Whenever Shares are to be issued upon the exercise of this Warrant, the Company
shall have the right to require the Holder to remit to the Company in cash an amount sufficient to
satisfy U.S. federal, state and local withholding tax requirements, if any, prior to the delivery
of any certificate or certificates for such Shares.

          8.2 Notwithstanding Section 8.1, at the election of a Holder, subject to the
approval of the Board of Directors of the Company, when Shares are to be issued upon the exercise
of this Warrant, the Holder may tender to the Company a number of Shares, or the Company shall
withhold a number of such Shares, the fair market value of which is sufficient to satisfy the tax
requirements, if any, attributable to such exercise or occurrence.

     9. Reservation of Securities. The Company shall at all times reserve and keep
available out of its authorized but unissued shares of Common Stock, solely for the purpose of
issuance upon the exercise of this Warrant, such
number of shares of Common Stock as shall be issuable upon the exercise hereof. The Company
covenants and agrees that, upon exercise of this Warrant and payment of the Exercise Price
therefore, all Shares issuable upon such exercise shall be duly and validly issued, fully paid and
non-assessable.

     10. No Rights as Shareholders. Nothing contained in this Warrant confers or shall be
construed as conferring upon the Holder hereof the right to vote or to consent or to receive notice
as a shareholder in respect of any meetings of shareholders for the election of directors or any
other matter, or as having any rights whatsoever as a shareholder of the Company.

4

 

     11. Notices. All notices, requests, consents and other communications hereunder shall
be in writing and shall be deemed to have been duly made when delivered, when sent by a nationally
recognized overnight courier or when mailed by registered or certified mail, return receipt
requested:

          (a) If to the registered Holder of this Warrant, to the address of such Holder as shown on the
books of the Company; or

          (b) If to the Company, to SinoFresh HealthCare, Inc., 516 Paul Morris Drive, Englewood,
Florida 34223, Attention: Chief Financial Officer, or to such other address as the Company may
designate by notice to the Holder.

     12. Successors. All of the covenants, agreements, representations and warranties
contained in this Warrant shall bind the parties hereto and their respective heirs, executors,
administrators, distributes, successors and assigns.

     13. Headings. The headings in this Warrant are intended for convenience only and
shall have no substantive effect.

     14. Governing Law. This Warrant shall be construed and enforced in accordance with,
and governed by, the laws of the State of Florida, without giving effect to conflict of law
principles.

     15. Amendment . The provisions of this Warrant may be waived, amended,
supplemented or modified (either prospectively or retroactively) either (i) by the written
agreement of the Company and the Holders of the right to purchase at least a majority of the
remaining Shares purchasable hereunder or (ii) in accordance with the Letter.

          IN WITNESS WHEREOF, the Company has caused this Warrant to be signed by its duly
authorized officer.

	 	 	 	 	 	 	 
	 	 	SINOFRESH HEALTHCARE, INC.	 	 
	 
	 	 	 	 	 	 
	

	 	By:	 	 	 	 
	

	 	 	 	

	 	 
	

	 	 	 	     Charles A. Fust	 	 
	

	 	 	 	     Chief Executive Officer	 	 
	Dated as of February 24, 2004
	 	 	 	 	 	 

5

 

Exhibit A

FORM OF EXERCISE AGREEMENT

Date: ______ _____, 200__

		
	To: 	SinoFresh HealthCare, Inc.

     The undersigned, pursuant to the provisions set forth in the within Warrant, hereby agrees to
purchase                      shares of Common Stock covered by such Warrant, and makes payment herewith
in full therefor at the price per share provided by such Warrant in cash or by certified or
official bank check or by wired funds in the amount of, or, by surrender of securities issued by
the Company (including a portion of the Warrant) having a market value (in the case of portion of
this Warrant, determined in accordance with Section 2 of the Warrant) equal to $___. Please
issue a certificate or certificates for such shares of Common Stock in the name of and pay any cash
for any fractional share to:

	 	 	 	 	 
	

	 	Name:	 	 
	

	 	 	 	 
	 
	 	 	 	 
	

	 	Signature:	 	 
	

	 	 	 	 
	 
	 	 	 	 
	

	 	Address:	 	 
	

	 	 	 	 
	 
	 	 	 	 
	

	 	Note:
	 	The above signature should correspond
exactly with the name on the face of the
within Warrant, if applicable.

and, if said number of shares of Common Stock shall not be all the shares purchasable under the
within Warrant, a new Warrant is to be issued in the name of said undersigned covering the balance
of the shares purchasable thereunder less any fraction of a share paid in cash.

6exv4w2

 

Exhibit 4.2

REGISTRATION RIGHTS AGREEMENT

     THIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of February 24, 2005 by and
between SinoFresh HealthCare, Inc., a Florida corporation (the “Company”), and AdSouth Partners,
Inc. (the “Holder.”)

     WHEREAS, the Company has agreed to issue to Holder a common stock purchase warrant (the
“Warrant”) for One Hundred Thousand (100,000) shares (the “Common Stock Shares”) of its common
stock, no par value per share (the “Common Stock”), in payment for certain services provided; and

     WHEREAS, the Company has agreed to enter into this Agreement and grant to the Holder the
registration rights herein.

     NOW, THEREFORE, in consideration of the premises, promises and the mutual covenants contained
herein, the Company and Holder hereby agree as follows:

1. Certain Definitions. As used in this Agreement, the following capitalized terms shall
have the following meanings:

               “Commission” shall mean the Securities and Exchange Commission.

               “Effective Date” shall mean the date the Company executes this Agreement.

               “Exchange Act” shall mean the Securities Exchange Act of 1934, as amended.

               “Registrable Stock” shall mean the Common Stock Shares issuable upon exercise of the Warrant,
excluding Common Stock Shares: (a) which have been registered under the Securities Act pursuant to
an effective registration statement filed thereunder and disposed of in accordance with the
registration statement covering them; or (b) which could be, in the opinion of counsel to the
Company, publicly sold as of the date in question pursuant to Rule 144 under the Securities Act.

               “Securities Act” shall mean the Securities Act of 1933, as amended.

2. Registration Rights.

               (a) “Piggyback Registration”. If the Company at any time or from time to time
proposes to register any of its Common Stock under the Securities Act (other than in connection
with: (i) a registration on Form S-4 pertaining to a merger or similar transaction; or (ii)
registration on Form S-8, or similar forms) the Company shall request that the managing underwriter
(if any) of such underwritten offering include the Registrable Stock in the registration statement
for the underwritten offering in such registration. If such managing underwriter agrees to include
the Remittable Stock in the registration statement relating to the underwritten offering, the
Company shall at such time give prompt written notice to the Holder of its intention to effect such
registration and of such Holder’s right under such proposed registration, and upon the request of the

1

 

Holder delivered to the Company within ten (10) days after giving such notice (which request shall
specify the Registrable Stock intended to be disposed of by the Holder), the Company shall use its
reasonable best efforts to include such Registrable Stock held by the Holder requested to be
included in such registration; provided, however, that:

                    (i) If the underwriter of the Company’s proposed offering with respect to which the Holder has
made a request pursuant to Section 2(a) advises the Company in writing that such inclusion is
likely to adversely affect the market for the securities being registered for sale by the Company,
the Company may refuse to include any of the Holder’s Registrable Stock in the registration
statement filed with respect to such offering; provided, however, that if such
underwriter advises the Company in writing that, in its opinion, the dollar amount or number of
securities requested to be included in such registration exceeds the dollar amount or number of
securities which can be sold in such offering, the amount of securities to be included in the
Company’s proposed offering and held by the Holder and all other holders having similar “piggyback”
rights as the Holder shall be reduced by the amount indicated by the underwriter on a pro rata
basis among all of such holders with such reduction allocated in proportion to the total number of
securities each of such holders initially sought to have registered in connection with the
Company’s proposed offering.

                    (ii) the Company may, in its sole discretion and without the consent of the Holder, delay the
filing or effectiveness of the registration statement or withdraw such registration statement and
abandon the proposed offering in which the Holder had requested to participate, but any abandonment
shall not preclude Holder’s subsequent request for registration pursuant to this Section 2 (a).

               (b) Option to Include Registrable Stock in Offering. The Holder, subject to the
provisions of Section 2(a), shall have the option to include any of the Holder’s Registrable Stock
in the registration statement. The Company shall not be required to include the Holder’s
Registrable Stock in the registration statement relating to an underwritten offering of the
Company’s securities unless the Holder accepts the terms of the underwriting as agreed upon between
the Company and the underwriters selected by it (provided such terms are usual and customary for
selling stockholders) and the Holder agrees to execute and/or deliver such documents in connection
with such registration as the Company or the managing underwriter may reasonably request.

               (c) Cooperation with Company. The Holder will cooperate with the Company in all
respects in connection with this Agreement, including, timely supplying all information reasonably
requested by the Company and executing and returning all documents reasonably requested in
connection with the registration and sale of the Registrable Stock.

3. Registration Procedures.

               (a) In connection with any registration under Section 2(a) hereof, the Company agrees as
follows:

                    (i) use its reasonable best efforts to cause such registration statement to become effective
and remain effective for the period of the distribution contemplated thereby (determined as
hereinafter provided).

2

 

                    (ii) prepare and file with the Commission such amendments and supplements to such registration
statement and the prospectus used in connection therewith as may be necessary to keep such
registration statement effective for the period specified in Section 3(a) and to comply with the
provisions of the Securities Act with respect to the sale or other disposition of all Registrable
Stock covered by such registration statement in accordance with the sellers’ intended method of
disposition set forth in such registration statement for such period;

                    (iii) furnish to Holder such numbers of copies of a summary prospectus or other prospectus,
including a preliminary prospectus or any amendment or supplement to any prospectus, in conformity
with the requirements of the Securities Act, and such other documents, as such persons may
reasonably request in order to facilitate the public sale or other disposition of the Registrable
Stock covered by such registration statement;

                    (iv) use its reasonable best efforts to register and qualify the Registrable Stock covered by
such registration statement under such other securities or blue sky laws of such jurisdiction as
the Holder, in the case of an underwritten public offering, the managing underwriter, reasonably
shall request, and do any and all other acts and things which may be necessary or advisable to
enable the Holder to consummate the public sale or other disposition in such jurisdiction of the
Registrable Stock, except that the Company shall not for any such purpose be required to: (i)
qualify to do business as a foreign corporation in any jurisdiction wherein it is not so qualified
or to file therein any general consent to service of process or be subject to any escrow or other
similar conditions; or (ii) take any other actions or submit itself or its directors or officers to
any restrictions, obligations or burdens having a material adverse economic effect on it or them;

                    (v) use its reasonable best efforts to list or cause to be quoted such securities on any
securities exchange or national quotation service on which any securities of the Company are then
listed or quoted, if the listing or quotation of such securities is then permitted under the rules
of such exchange or national quotation service;

                    (vi) enter into and perform its obligations under an underwriting agreement, if the offering
is an underwritten offering, in usual and customary form, with the managing underwriter or
underwriters of such underwritten offering; and

                    (vii) notify Holder and each underwriter under such registration statement, if any, at any
time when a prospectus relating thereto is required to be delivered under the Securities Act, of
the happening of any event of which it has knowledge as a result of which the prospectus included
in such registration statement, as then in effect, includes an untrue statement of a material fact
or omits to state a material fact required to be stated therein or necessary to make the statements
therein not misleading in the light of the circumstances then existing.

               (b) For purposes of Sections 3(a) and 3(b) hereof, the period of distribution of Registrable
Stock in a firm commitment underwritten public offering shall be deemed to extend until each
underwriter has completed the distribution of all securities purchased by it, and the period of
distribution of Registrable Stock in any other registration shall be deemed to extend until the
earlier of the sale of all Registrable Stock

3

 

covered thereby or 30 days (or such other amount of time as determined by the Company in its
sole discretion).

4. Expiration of Registration Rights. The obligations of the Company to register shares of
the Registrable Stock under Section 2 of this Agreement, shall terminate one year after the date of
this Agreement, unless such obligations terminate earlier in accordance with the terms of this
Agreement.

5. Expenses. All expenses incurred by the Company in complying with the provisions of this
Agreement, including, without limitation, all filing fees, printing expenses, fees and
disbursements of Company counsel and independent public accounts for the Company, fees and expenses
(including counsel fees) incurred in connection with complying with state securities or “blue sky”
laws, fees of the National Association of Securities Dealers, Inc., fees of transfer agents and
registrars and costs of issuance, but excluding any Selling Expenses and expenses of counsel for
any Holder of the Registrable Stock, are called “Registration Expenses.” All underwriting
discounts, selling commissions and underwriter expense reimbursement allowances applicable to the
sale of Registrable Stock, any stock transfer taxes incurred with respect to the sale of
Registrable Stock, as well as all fees and expenses of Holder’s legal counsel and other advisors,
are called “Selling Expenses.”

The Company will pay all Registration Expenses in connection with each registration of Registrable
Stock pursuant to the provisions of this Agreement. All Selling Expenses in connection with each
such registration statement shall be borne by the Holder.

6. Indemnification. In the event any Registrable Stock are included in a registration
statement pursuant to this Agreement:

               (a) Company Indemnity. To the extent permitted by law, the Company shall indemnify
and hold harmless the Holder hereunder, its officers and directors, each underwriter of such
Registrable Stock thereunder and each other person, if any, who controls such Holder or underwriter
within the meaning of the Securities Act, against any losses, claims, damages, liabilities or
expenses to which they may become subject under the Securities Act or other federal or state law,
insofar as such losses, claims, damages, liabilities, or expenses (or actions in respect thereof)
arise out of or are based upon: (i) any untrue statement or alleged untrue statement of a material
fact contained in such registration statement including any preliminary prospectus or final
prospectus contained therein or any amendments or supplements thereto; (ii) the omission or alleged
omission to state therein a material fact required to be stated therein, or necessary to make the
statements therein, in light of the circumstances under which they were made, not misleading, and
the Company shall reimburse the Holder, each such underwriter and each such controlling person for
any legal or other expenses reasonably incurred by them in connection with investigating or
defending any such loss, claim, damage, liability, expense or action; provided, however, that the
Company shall not be liable in any such case if and to the extent that any such loss, claim,
damage, liability, expense or action arises out of or is based upon: (i) an untrue statement or
alleged untrue statement or omission or alleged omission so made in conformity with information
furnished by any such Holder, any such underwriter or any such controlling person in writing
specifically for use in such registration statement or prospectus; or (ii) such Holder’s failure to
deliver a copy of the final prospectus as then amended or supplemented after the Company has
furnished such Holder with a sufficient number of

4

 

copies of the same, but only if delivery of same is required by law and the same would have
cured the defect giving rise to any such loss, claim, damage, liability, expense or action.

               (b) Holder Indemnity. In the event of a registration of any of Holder’s Registrable
Stock under the Securities Act pursuant to the provisions of this Agreement, the Holder shall
furnish to the Company in writing such information and affidavits with respect to such Holder as
the Company reasonably requests for use in connection with any such registration statement (or
prospectus contained therein) and the Holder will indemnify and hold harmless to the extent
permitted by law, the Company, each person, if any, who controls the Company within the meaning of
the Securities Act, each officer and director of the Company, each underwriter and each person who
controls any underwriter within the meaning of the Securities Act, against all losses, claims,
damages, liabilities or expenses to which the Company or such officer, director, underwriter or
controlling person may become subject under the Securities Act or other-wise, insofar as such
losses, claims, damages, liabilities or expenses (or actions in respect thereof) arise out of or
are based upon any statements or information provided by the Holder to the Company or underwriter
in connection with the offer and sale of Registrable Stock. Notwithstanding the foregoing, the
amount Holder shall be obligated to indemnify pursuant to this Agreement shall be limited to an
amount equal to the proceeds received by Holder of the Registrable Stock sold pursuant to the
registration statement which gives rise to such obligation to indemnify.

               (c) Notice; Right to Defend. Any person entitled to indemnification hereunder agrees
to give prompt written notice to the indemnifying party after the receipt by such person of any
written notice of the commencement of any action, suit, proceeding or investigation or threat
thereof made in writing for which such person will claim indemnification or contribution pursuant
to this Agreement and, unless in the reasonable judgment of such indemnified party a conflict of
interest may exist between such indemnified party and the indemnifying party, shall permit the
indemnifying party to assume the defense of such claim with counsel reasonably satisfactory to such
indemnified party. If the indemnifying party is not entitled to, or elects not to, assume the
defense of a claim, it will not be obligated to pay the fees and expenses of more than one counsel
for the indemnified party with respect to such claim. The indemnifying party will not be subject
to any liability for any settlement made without its consent. Failure of notice by a seller of
Registrable Stock entitled to indemnification hereunder will not relieve the Company of its
obligations under this Section 6 unless the Company is actually prejudiced thereby.

               (d) Contribution. If the indemnification provided for in this Agreement is held by a
court of competent jurisdiction to be unavailable to an indemnified party with respect to any loss,
liability, claim, damage or expense referred to therein, then the indemnifying party, in lieu of
indemnifying such indemnified party thereunder, shall contribute to the amount paid or payable by
such indemnified party as a result of such loss, liability, claim, damage or expense in such
proportion as is appropriate to reflect the relative fault of the indemnifying party on the one
hand and of the indemnified party on the other hand in connection with the statements or omissions
which resulted in such loss, liability, claim, damage or expense as well as any other relevant
equitable considerations. The relevant fault of the indemnifying party and the indemnified party
shall be determined by reference to, among other things, whether the untrue or alleged untrue
statement of a material fact or the omission to state a material fact relates to

5

 

information supplied by the indemnifying party or by the indemnified party and the parties’
relative intent, knowledge, access to information and opportunity to correct or prevent such
statement or omission.

               (e) Survival of Indemnity, The indemnification provided by this Agreement shall be a
continuing right to indemnification and shall survive the registration and sale of any Registrable
Stock by any person entitled to indemnification hereunder and the expiration or termination of this
Agreement.

8. Assignment of Registration Rights. The rights of the Holder under this Agreement,
including the rights to cause the Company to register Registrable Stock may not be assigned without
the written prior consent of the Company. In the event of any transfer, the transfer will only be
permitted if the transferee agrees to be bound by the provisions of this Agreement.

9. Notices.

               (a) All communications under this Agreement shall be in writing and shall be mailed by
certified mail return receipt requested, postage prepaid, or telegraphed or telexed with
confirmation of receipt or delivered by hand or by overnight delivery service,

                    (i)
If to the company, at:

	 	 	 	 	 

	

	 	 	 	SinoFresh HealthCare, Inc.
	

	 	 	 	516 Paul Morris Drive
	

	 	 	 	Englewood, Florida 34223
	

	 	 	 	Attn: Charles A. Fust, Chief Executive Officer

or at such other address as it may have furnished in writing to the Holder of Registrable Stock at
the time outstanding, or

                    (ii) if to the Holder of any Registrable Stock, to the address of such Holder as it appears in
the stock ledger of the Company.

               (b) Any notice so addressed, when mailed by certified mail return receipt requested shall be
deemed to be given three days after so mailed, when telegraphed or telexed shall be deemed to be
given when transmitted, or when delivered by hand or overnight delivery service shall be deemed to
be given when delivered.

10. Successors and Assigns. Except as otherwise expressly provided herein, this Agreement
shall inure to the benefit of and be binding upon the successors and permitted assigns of the
Company and the Holder.

11. Amendment, Waiver and Termination. This Agreement may be amended, and the observance
of any term of this Agreement may be waived, but only with the written consent of the Company and
the Holder.

12. Counterparts. One or more counterparts of this Agreement may be signed by the parties,
each of which shall be an original but all of which together shall constitute one and the same
instrument.

6

 

13. Governing Law. This Agreement shall be construed in accordance with and governed by
the internal laws of the State of Florida, without giving effect to conflicts of law principles.

14. Invalidity of Provisions. If any provision of this Agreement is or becomes invalid,
illegal or unenforceable in any respect, the validity, legality and enforceability of the remaining
provisions contained herein shall not be affected thereby.

15. Headings. The headings in this Agreement are for convenience of reference only and
shall not be deemed to alter or affect the meaning or interpretation of any provisions hereof.

16. Entire Agreement. This Agreement expresses the entire understanding of the company and
the Holder with respect to the subject matter hereof and supersedes all prior and contemporaneous
agreements and undertakings of the Company and the Holder with respect to the subject matter
hereof.

     IN WITNESS WHEREOF, the undersigned have executed this Agreement effective as of the day and
year first above written.

	 	 	 	 	 	 	 	 	 
	

	 	 	 	 	 	 	 	 
	SINOFRESH HEALTHCARE, INC.	 	ADSOUTH PARTNERS, INC.
	 
	 	 	 	 	 	 	 	 
	By:
	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 
	

	 	Name: Charles Fust
	 	 	 	Name:	 	 
	

	 	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 
	

	 	Title: Chairman and CEO
	 	 	 	Title:	 	 
	

	 	 	 	 	 	 	 	 

7

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00085-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00085-of-00352.parquet"}]]